“Currently, there are no effective means to treat Alzheimer’s disease or definitely diagnose this condition during life. We have recently shown that the protein, butyrylcholinesterase (BChE) typically presents in high levels in the Alzheimer’s disease brain and is a very speci...
“We’re investigating key factors that affect the practical, psychological, and social lives of Canadian family members who are employed while also providing care to a senior with dementia at home. Our goal is to understand the challenges of this dual role and respond to those ...
On March 27, 2017, a team of researchers within the Canadian Consortium on Neurodegeneration in Aging (CCNA) disseminated the first Indigenous-specific health promotion materials available in Canada According to the team’s principal investigator, Dr. Kristen Jacklin: ...
“Researchers and clinicians must embrace the complexity of dementia to gain a clearer understanding of the whole person and the risks they are confronted with. This approach will have a direct impact on the quality of life and quality of care received by people living with dem...
“While the role of the brain’s blood vessels is increasingly recognized in dementia research, models that capture the normal functioning that occurs in human brains are lacking. In an effort to fill this gap, my lab bioengineered a human vascular model. Scientists will be able...
“Our SYNERGIC Trial will support preventative treatment for dementia by showing how cognition can be improved through combining exercise with cognitive training. This will help to lay out future clinical guidelines for physicians whose patients are at risk of developing dement...
The following letter was sent to the Minister of Health, Dr. Jane Philpott by the CCNA’s Scientific Director, Dr. Howard Chertkow RE: Canada Needs a Greater Investment in Dementia Research As the Scientific Director of the Canadian Consortium on Neurodegene...
For many older adults, being licensed to drive and having access to a vehicle are associated with mobility and independence. Set against this backdrop, driving retirement tends to be viewed as losing a privilege, losing the ability to move about freely, and being reliant on ot...
“It’s unlikely that any therapy will be effective after the clinical presentation of Alzheimer’s disease. The best chance we have to alter its course is to intervene at earlier stages.” Dr. A. Claudio Cuello Alzheimer’s disease develops decades before it can be clinically dete...
A Q&A with James Lind Alliance (JLA) project coordinator, Jennifer Bethell 1) How does the James Lind Alliance help advance dementia research? The James Lind Alliance (JLA) brings together patients, care partners and clinicians in what they call “priority setting partners...